In this study, we have finally demonstrated that CPNE7 is associated with the initiation, progression, and metastasis of colorectal cancer, and through further studies in the future, we will be able to confirm its potential as a gene therapy or biomarker for colorectal cancer patients. This evidence concerns the gene CPNE7 and colorectal cancer.